
Keytruda (pembrolizumab) produced better overall survival (OS) rates than chemotherapy for patients with recurrent, advanced urothelial carcinoma.

Keytruda (pembrolizumab) produced better overall survival (OS) rates than chemotherapy for patients with recurrent, advanced urothelial carcinoma.

After losing someone to cancer, people may need continued support.

Emotional care - just like life-saving treatment - is critical to survival.

Every six months, I get an MRI to check for recurrence or growth of my brain tumor. This is one of those times. To prepare for tomorrow, I try to remember not to forgo today.

Women with breast cancer who are positive for the BRCA gene mutation may be more likely to encounter difficulty with fertility preservation compared to women with breast cancer who have tested negative for the BRCA mutation.

Patients with advanced gastric cancer tend to use their health care resources more often and have a worse quality of life than those without the disease

While many people associate the strategy with the end of life, studies have shown that employing palliative care earlier in the course of treatment can benefit patients’ outcomes and quality of life.

Side effects that arise months or years after adolescents and young adults (AYAs) have completed cancer treatment — known as late effects — can significantly affect both careers and quality of life in this population.

Nausea and vomiting are no longer top concerns for patients undergoing chemotherapy. Socio-psychological concerns, instead, have jumped to the forefront.

A phase 2 trial – which is still enrolling patients – is investigating multiple targeted agents for the treatment of patients with glioblastoma (GBM).

According to the results of a recent study conducted in China, patients with stage 3B/4 non-small cell lung cancer (NSCLC) saw a 3.3-month increase in median progression-free survival (PFS) when taking Conmana (icotinib) compared to those who were taking chemotherapy.

Women want bilateral mastectomy more often, and many are getting it.

It is normal to feel guilt when you survived cancer and friends and family members do not. Here is one writer's way of coping.

Be prepared. After cancer, other medical issues can trigger outsized emotional responses.

The Food and Drug Administration (FDA) recently released a statement providing data from the two phase 3 trials testing Keytruda (pembrolizumab) in patients with multiple myeloma. The trials were placed on clinical holds by the FDA in July, after concerns arose regarding the drug’s safety in this group of patients.

It's been said that reaching the ten-year mark means you are home free. But are you?

With the beginning of the new school year approaching, some parents might be wondering how to manage cancer treatments and the demands of being a parent.

Up-and-coming treatments for patients with triple-negative breast cancer (TNBC) may include immunotherapy combinations, according to Sylvia Adams, M.D.

September is Ovarian Cancer Awareness Month, but many people still aren’t aware of the symptoms and risk factors that can sometimes lead to an ovarian cancer diagnosis. Here are two steps you can take to personalize your approach to ovarian health management by being "ovarian self-aware."

The immunotherapy agent Keytruda (pembrolizumab) had an overall response rate (ORR) of 33 percent in a recent trial including patients with extensive-stage small cell lung cancer (SCLC). Findings of the phase 1b KEYNOTE-028 trial were published in the Journal of Clinical Oncology.

As unpredictable as the weather, the cycle of cancer is often difficult to forecast.

Tips for coping include finding simple ways to pass time and not being in a hurry to go anywhere.

If I’d known I would forget so easily, I would have snapped a photo. I could have easily locked the photo away for safe keeping. When I got the urge to remember, I could have pulled out the photo and looked, but would that have really been a good thing?

A recent study looked at the financial effects that many survivors of childhood cancer face.

In a recent study, researchers were working on identifying different molecular targets to better provide personalized care to patients with ovarian cancer. To do this, they examined more than 4,000 tumor specimins.

A new drug may be on the way to treat patients with advanced melanoma, as the FDA granted LN-144, which is produced by Iovance Biotherapeutics, a fast track designation. The drug uses tumor-infiltrating lymphocyte (TIL) technology to bolster the body’s immune system to attack cancer cells.

A cancer diagnosis robs us of many things. For an avid traveler, its like a bird being trapped in a cage.

A breast cancer and melanoma survivor who also speaks and writes about clutter clearing shares some cancer clutter clearing tips.

Stress reduction is a vital part of breast cancer survivorship. Learn how one survivor incorporated the word

There is a relationship between the genetics of BRCA1 and BRCA2 mutations and the risk of a patient with breast or ovarian cancer being resistant to platinum-based chemotherapy, according to recent research conducted at the Perelman School of Medicine at the University of Pennsylvania. The study’s senior author Katherine Nathanson, M.D., spoke with CURE about these findings.